Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: An in silico study

Journal of Diabetes Science and Technology

Volumn 4, Issue 3, 2010, Pages 562-570

  Breton, Marc D ^a   Kovatchev, Boris P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Blood glucose; Diabetes; Glycemic control; Hypoglycemia; Meter accuracy; Simulations

Indexed keywords

ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; COMPUTER SIMULATION; DRUG SELF ADMINISTRATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; RISK FACTORS; SELF ADMINISTRATION;

EID: 78149382135     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400309     Document Type: Article

References (40)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
2. Reichard P, Phil M. Mortality and treatment side effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention study. Diabetes. 1994;43(2):313-7. (Pubitemid 24033687)
3. UK Prospective Diabetes Study Group (UKPDS). Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352(9131):837-53.
4. White NH, Skor DA, Cryer PE, Levandoski L, Santiago JV. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983;308(9):485-91. (Pubitemid 13195475)
5. Cryer PE, Gerich JE. Glucose counterregulation, hypoglycemia, and intensive therapy of diabetes mellitus. N Engl J Med. 1985;313(4):232-41. (Pubitemid 15068639)
6. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes. 1988;37(7):901-7. (Pubitemid 19043718)
7. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med. 1987;316(22):1376-83. (Pubitemid 17079681)
8. Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes. 1992;41(3):255-60.
9. Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes. 1994;43(11):1378-89.
10. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45(7):937-48. (Pubitemid 34762188)
11. Santiago JV. Lessons from the Diabetes Control and Complications Trial. Diabetes. 1993;42(11):1549-54. (Pubitemid 23318108)
12. Krouwer JS, Cembrowski GS. A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol. 2010;4(1):75-83.
13. Lippi G, Salvagno GL, Guidi GC, Negri M, Rizzotti P. Evaluation of four portable self-monitoring blood glucose meters. Ann Clin Biochem. 2006;43(Pt 5):408-13. (Pubitemid 44526542)
14. Chen ET, Nichols JH, Duh SH, Hortin G. Performance evaluation of blood glucose monitoring devices. Diabetes Technol Ther. 2003;5(5):749-68. (Pubitemid 37339538)
15. Kilo C, Pinson M, Joynes JO, Joseph H, Monhaut N, Parkes JL, Baum J. Evaluation of a new blood glucose monitoring system with auto-calibration. Diabetes Technol Ther. 2005;7(2):283-94. (Pubitemid 40586372)
16. Bergenstal RM. Evaluating the accuracy of modern glucose meters. Insulin. 2008;3:5-14. (Pubitemid 351331167)
17. Alto WA, Meyer D, Schneid J, Bryson P, Kindig J. Assuring the accuracy of home glucose monitoring. J Am Board Fam Pract. 2002;15(1):1-6.
18. Hirsch IB, Bode BW, Childs BP, Close KL, Fisher WA, Gavin JR, Ginsberg BH, Raine CH, Verderese CA. Self-monitoring of blood glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research. Diabetes Technol Ther. 2008;10(6):419-39.
19. Boren SA, Clarke WL. Analytical and clinical performance of blood glucose monitors. J Diabetes Sci Technol. 2010;4(1):84-97.
20. Raine CH, Pardo S, Parkes JL. Predicted blood glucose from insulin administration based on values from miscoded glucose meters. J Diabetes Sci Technol. 2008;2(4):557-62.
21. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47(2):209-14. (Pubitemid 32142918)
22. Boyd JC, Bruns DE. Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests: meeting clinical needs. Methods Enzymol. 2009;467:411-33.
23. Dalla Man C, Rizza RA, Cobelli C. Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng. 2007;54(10):1740-9. (Pubitemid 47450539)
24. Dalla Man C, Raimondo DM, Rizza RA, Cobelli C. GIM, simulation software of meal glucose-insulin model. J Diabetes Science Technol. 2007;1(3):323-30.
25. Kovatchev BP, Breton M, Dalla Man CD, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
26. Zisser H, Robinson L, Bevier W, Dassau E, Ellingsen C, Doyle FJ, Jovanovic L. Bolus calculator: a review of four "smart" insulin pumps. Diabetes Technol Ther. 2008;10(6):441-4.
27. Kovatchev BP. Accuracy of continuous glucose monitoring alarms and its relationship to the effectiveness of open and closed-loop control. In: Proceedings of the 9th Diabetes Technology Meeting; San Francisco, CA; 2009.
28. ISO 15197. In vitro diagnostic test systems - requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: International Organization for Standardization; 2003.
29. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the hemoglobin A1c assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-8.
30. Kovatchev BP. Mathematical methods for expressing and quantifying glucose variability. Proceedings of the 7th Diabetes Technology Meeting; San Francisco, CA; 2007.
31. Magni L, Raimondo DM, Man CD, Breton M, Patek S, Nicolao GD, Cobelli C, Kovatchev BP. Evaluating the efficacy of closed-loop glucose regulation via control-variability grid analysis. J Diabetes Sci Technol. 2008;2(4):630-5.
32. Clarke W, Kovatchev B. Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther. 2009;11 Suppl 1:S45-54.
33. Box GE, Draper NR. Empirical model-building and response surfaces (Wiley Series in Probability and Statistics). New York: John Wiley & Sons, Inc.; 1987.
34. Benhabib B. Manufacturing: design, production, automation and integration. New York: Marcel Dekker; 2003.
35. Eddy DM, Schlessinger L. Archimedes: a trial-validate model of diabetes. Diabetes Care. 2003;26(11):3093-101.
36. Eddy DM, Schlessinger L. Validation of the archimedes diabetes model. Diabetes Care. 2003;26(11):3102-10. (Pubitemid 37339505)
37. Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol. 2009;3(5):1109-20.
38. Magni L, Raimondo DM, Bossi L, Man CD, De Nicolao G, Kovatchev B, Cobelli C. Model predictive control of type 1 diabetes: an in silico trial. J Diabetes Sci Technol. 2007;1(6):804-12.
39. Patek SD, Breton MD, Chen Y, Solomon C, Kovatchev B. Linear quadratic gaussian-based closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2007;1(6):834-841.
40. Cobelli C, Dalla Man C, Sparacino G, Magni L, Nicolao G, Kovatchev BP. Diabetes: models, signals, and control. IEEE Rev Biomed Eng. 2009;2:54-96.